U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C21H32N.Cl
Molecular Weight 333.938
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LAURYL ISOQUINOLINIUM CHLORIDE

SMILES

[Cl-].CCCCCCCCCCCC[N+]1=CC=C2C=CC=CC2=C1

InChI

InChIKey=WBXDKDRNXQVSGV-UHFFFAOYSA-M
InChI=1S/C21H32N.ClH/c1-2-3-4-5-6-7-8-9-10-13-17-22-18-16-20-14-11-12-15-21(20)19-22;/h11-12,14-16,18-19H,2-10,13,17H2,1H3;1H/q+1;/p-1

HIDE SMILES / InChI
Lauryl isoquinolium bromide is one of the active components of Decelerine a cosmetic product which is used for its soothing, moisturizing and regenerating effects on the skin.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
Unknown

Approved Use

Unknown

Sample Use Guides

Decelerine (one of the components is Lauryl isoquinolium bromide) must be incorporated into the water phase. If the processing requires heating, it must be added at the final step of the manufacturing process. A dosage of 3% decelerine in final formulation is recommended.
Route of Administration: Topical
In Vitro Use Guide
Unknown
Name Type Language
2-DODECYLISOQUINOLINIUM CHLORIDE
Preferred Name English
LAURYL ISOQUINOLINIUM CHLORIDE
Systematic Name English
ISOQUINOLINIUM, 2-DODECYL-, CHLORIDE
Systematic Name English
N-LAURYLISOQUINOLINIUM CHLORIDE
Systematic Name English
ISOQUINOLINIUM, 2-DODECYL-, CHLORIDE (1:1)
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID90992349
Created by admin on Mon Mar 31 22:23:09 GMT 2025 , Edited by admin on Mon Mar 31 22:23:09 GMT 2025
PRIMARY
CAS
71732-96-2
Created by admin on Mon Mar 31 22:23:09 GMT 2025 , Edited by admin on Mon Mar 31 22:23:09 GMT 2025
PRIMARY
FDA UNII
W21ZNV8R6L
Created by admin on Mon Mar 31 22:23:09 GMT 2025 , Edited by admin on Mon Mar 31 22:23:09 GMT 2025
PRIMARY
PUBCHEM
51393
Created by admin on Mon Mar 31 22:23:09 GMT 2025 , Edited by admin on Mon Mar 31 22:23:09 GMT 2025
PRIMARY